25 XP   0   0   10

Sinopharm Group Co Ltd
Buy, Hold or Sell?

Let's analyse Sinopharm Group Co Ltd together

PenkeI guess you are interested in Sinopharm Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sinopharm Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sinopharm Group Co Ltd

I send you an email if I find something interesting about Sinopharm Group Co Ltd.

Quick analysis of Sinopharm Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Sinopharm Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.41
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$23.59
Expected worth in 1 year
HK$32.16
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
HK$11.82
Return On Investment
59.7%

For what price can you sell your share?

Current Price per Share
HK$19.78
Expected price per share
HK$17.14 - HK$22.95
How sure are you?
50%

1. Valuation of Sinopharm Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$19.78

Intrinsic Value Per Share

HK$28.80 - HK$96.88

Total Value Per Share

HK$52.39 - HK$120.47

2. Growth of Sinopharm Group Co Ltd (5 min.)




Is Sinopharm Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$9.4b$8.5b$853.8m9.1%

How much money is Sinopharm Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.1b$1b$105.9m9.0%
Net Profit Margin1.5%1.5%--

How much money comes from the company's main activities?

3. Financial Health of Sinopharm Group Co Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of Sinopharm Group Co Ltd? (5 min.)

Welcome investor! Sinopharm Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Sinopharm Group Co Ltd.

What can you expect buying and holding a share of Sinopharm Group Co Ltd?

First you should know what it really means to hold a share of Sinopharm Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sinopharm Group Co Ltd is HK$19.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sinopharm Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sinopharm Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$23.59. Based on the TTM, the Book Value Change Per Share is HK$2.14 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-9.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.81 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sinopharm Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.381.9%0.381.9%0.341.7%0.321.6%0.261.3%
Usd Book Value Change Per Share0.271.4%0.271.4%-1.24-6.3%0.090.5%0.170.9%
Usd Dividend Per Share0.100.5%0.100.5%0.100.5%0.090.4%0.070.3%
Usd Total Gains Per Share0.381.9%0.381.9%-1.15-5.8%0.180.9%0.241.2%
Usd Price Per Share2.53-2.53-2.17-2.99-3.37-
Price to Earnings Ratio6.71-6.71-6.31-9.72-14.87-
Price-to-Total Gains Ratio6.72-6.72--1.89-4.68-9.84-
Price to Book Ratio0.84-0.84-0.79-0.92-1.37-
Price-to-Total Gains Ratio6.72-6.72--1.89-4.68-9.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.525906
Number of shares395
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.100.09
Usd Book Value Change Per Share0.270.09
Usd Total Gains Per Share0.380.18
Gains per Quarter (395 shares)148.9970.29
Gains per Year (395 shares)595.97281.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1164432586138143271
23278651182276287552
349112971778414430833
4655172923745515731114
5818216229706897171395
6982259435668278601676
711463026416296510031957
8130934584758110311472238
9147338915354124112902519
10163743235950137814332800

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%15.02.00.088.2%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.01.094.1%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%15.02.00.088.2%

Fundamentals of Sinopharm Group Co Ltd

About Sinopharm Group Co Ltd

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-15 18:06:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Sinopharm Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sinopharm Group Co Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sinopharm Group Co Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 1.5% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sinopharm Group Co Ltd:

  • The MRQ is 1.5%. The company is making a profit. +1
  • The TTM is 1.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%0.0%
TTM1.5%YOY1.5%+0.1%
TTM1.5%5Y1.6%0.0%
5Y1.6%10Y1.6%0.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%2.1%-0.6%
TTM1.5%2.0%-0.5%
YOY1.5%2.5%-1.0%
5Y1.6%2.2%-0.6%
10Y1.6%2.3%-0.7%
1.1.2. Return on Assets

Shows how efficient Sinopharm Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sinopharm Group Co Ltd to the Medical Distribution industry mean.
  • 2.3% Return on Assets means that Sinopharm Group Co Ltd generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sinopharm Group Co Ltd:

  • The MRQ is 2.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.3%0.0%
TTM2.3%YOY2.3%+0.0%
TTM2.3%5Y2.4%0.0%
5Y2.4%10Y2.5%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%1.6%+0.7%
TTM2.3%1.6%+0.7%
YOY2.3%1.2%+1.1%
5Y2.4%1.0%+1.4%
10Y2.5%1.4%+1.1%
1.1.3. Return on Equity

Shows how efficient Sinopharm Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sinopharm Group Co Ltd to the Medical Distribution industry mean.
  • 12.5% Return on Equity means Sinopharm Group Co Ltd generated $0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sinopharm Group Co Ltd:

  • The MRQ is 12.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.5%TTM12.5%0.0%
TTM12.5%YOY12.5%0.0%
TTM12.5%5Y12.9%-0.4%
5Y12.9%10Y12.6%+0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ12.5%3.7%+8.8%
TTM12.5%3.1%+9.4%
YOY12.5%2.8%+9.7%
5Y12.9%2.5%+10.4%
10Y12.6%3.2%+9.4%

1.2. Operating Efficiency of Sinopharm Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sinopharm Group Co Ltd is operating .

  • Measures how much profit Sinopharm Group Co Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sinopharm Group Co Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 4.1% means the company generated $0.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sinopharm Group Co Ltd:

  • The MRQ is 4.1%. The company is operating less efficient.
  • The TTM is 4.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.1%0.0%
TTM4.1%YOY4.0%+0.1%
TTM4.1%5Y4.1%+0.0%
5Y4.1%10Y4.0%+0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%2.9%+1.2%
TTM4.1%2.8%+1.3%
YOY4.0%3.9%+0.1%
5Y4.1%3.5%+0.6%
10Y4.0%3.4%+0.6%
1.2.2. Operating Ratio

Measures how efficient Sinopharm Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.87 means that the operating costs are $1.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sinopharm Group Co Ltd:

  • The MRQ is 1.872. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.872. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.872TTM1.8720.000
TTM1.872YOY1.874-0.002
TTM1.8725Y1.505+0.367
5Y1.50510Y1.233+0.272
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8721.642+0.230
TTM1.8721.594+0.278
YOY1.8741.431+0.443
5Y1.5051.365+0.140
10Y1.2331.229+0.004

1.3. Liquidity of Sinopharm Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sinopharm Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.36 means the company has $1.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sinopharm Group Co Ltd:

  • The MRQ is 1.359. The company is just able to pay all its short-term debts.
  • The TTM is 1.359. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.359TTM1.3590.000
TTM1.359YOY1.327+0.033
TTM1.3595Y1.313+0.046
5Y1.31310Y1.298+0.015
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3591.389-0.030
TTM1.3591.400-0.041
YOY1.3271.424-0.097
5Y1.3131.411-0.098
10Y1.2981.329-0.031
1.3.2. Quick Ratio

Measures if Sinopharm Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sinopharm Group Co Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.88 means the company can pay off $0.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sinopharm Group Co Ltd:

  • The MRQ is 0.884. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.884. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.884TTM0.8840.000
TTM0.884YOY0.935-0.050
TTM0.8845Y0.930-0.046
5Y0.93010Y0.905+0.026
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8840.730+0.154
TTM0.8840.745+0.139
YOY0.9350.798+0.137
5Y0.9300.784+0.146
10Y0.9050.850+0.055

1.4. Solvency of Sinopharm Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sinopharm Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sinopharm Group Co Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.81 means that Sinopharm Group Co Ltd assets are financed with 81.3% credit (debt) and the remaining percentage (100% - 81.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sinopharm Group Co Ltd:

  • The MRQ is 0.813. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.813. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.813TTM0.8130.000
TTM0.813YOY0.815-0.002
TTM0.8135Y0.753+0.060
5Y0.75310Y0.733+0.020
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8130.610+0.203
TTM0.8130.606+0.207
YOY0.8150.600+0.215
5Y0.7530.580+0.173
10Y0.7330.592+0.141
1.4.2. Debt to Equity Ratio

Measures if Sinopharm Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sinopharm Group Co Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 435.9% means that company has $4.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sinopharm Group Co Ltd:

  • The MRQ is 4.359. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.359. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.359TTM4.3590.000
TTM4.359YOY4.420-0.061
TTM4.3595Y4.137+0.222
5Y4.13710Y3.747+0.390
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3591.554+2.805
TTM4.3591.554+2.805
YOY4.4201.688+2.732
5Y4.1371.675+2.462
10Y3.7471.760+1.987

2. Market Valuation of Sinopharm Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sinopharm Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Sinopharm Group Co Ltd to the Medical Distribution industry mean.
  • A PE ratio of 6.71 means the investor is paying $6.71 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sinopharm Group Co Ltd:

  • The EOD is 6.694. Based on the earnings, the company is cheap. +2
  • The MRQ is 6.715. Based on the earnings, the company is cheap. +2
  • The TTM is 6.715. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.694MRQ6.715-0.020
MRQ6.715TTM6.7150.000
TTM6.715YOY6.308+0.407
TTM6.7155Y9.719-3.004
5Y9.71910Y14.874-5.155
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD6.69412.350-5.656
MRQ6.71514.424-7.709
TTM6.71515.740-9.025
YOY6.30818.720-12.412
5Y9.71915.472-5.753
10Y14.87419.379-4.505
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sinopharm Group Co Ltd:

  • The EOD is 3.077. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.087. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.087. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.077MRQ3.087-0.009
MRQ3.087TTM3.0870.000
TTM3.087YOY5.258-2.171
TTM3.0875Y76.038-72.952
5Y76.03810Y4.879+71.160
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD3.0776.479-3.402
MRQ3.0876.758-3.671
TTM3.0877.751-4.664
YOY5.2580.886+4.372
5Y76.0382.246+73.792
10Y4.8791.985+2.894
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sinopharm Group Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.84 means the investor is paying $0.84 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sinopharm Group Co Ltd:

  • The EOD is 0.838. Based on the equity, the company is cheap. +2
  • The MRQ is 0.841. Based on the equity, the company is cheap. +2
  • The TTM is 0.841. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.838MRQ0.841-0.003
MRQ0.841TTM0.8410.000
TTM0.841YOY0.791+0.050
TTM0.8415Y0.915-0.074
5Y0.91510Y1.368-0.453
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.8380.962-0.124
MRQ0.8411.157-0.316
TTM0.8411.157-0.316
YOY0.7911.208-0.417
5Y0.9151.257-0.342
10Y1.3681.922-0.554
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sinopharm Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.1432.1430%-9.725+554%0.710+202%1.335+60%
Book Value Per Share--23.59023.5900%21.447+10%25.812-9%20.984+12%
Current Ratio--1.3591.3590%1.327+2%1.313+4%1.298+5%
Debt To Asset Ratio--0.8130.8130%0.8150%0.753+8%0.733+11%
Debt To Equity Ratio--4.3594.3590%4.420-1%4.137+5%3.747+16%
Dividend Per Share--0.8110.8110%0.746+9%0.683+19%0.529+53%
Eps--2.9552.9550%2.689+10%2.507+18%2.016+47%
Free Cash Flow Per Share--6.4276.4270%3.226+99%3.903+65%3.040+111%
Free Cash Flow To Equity Per Share--4.4544.4540%-1.866+142%2.429+83%2.253+98%
Gross Profit Margin--1.0001.0000%1.0000%-0.151+115%-0.394+139%
Intrinsic Value_10Y_max--96.877--------
Intrinsic Value_10Y_min--28.801--------
Intrinsic Value_1Y_max--5.640--------
Intrinsic Value_1Y_min--3.032--------
Intrinsic Value_3Y_max--20.047--------
Intrinsic Value_3Y_min--9.038--------
Intrinsic Value_5Y_max--38.191--------
Intrinsic Value_5Y_min--14.918--------
Market Cap26541002749.440-133%61913818809.60061913818809.6000%52926325760.000+17%71201363552.710-13%75110784236.355-18%
Net Profit Margin--0.0150.0150%0.015+4%0.016-1%0.016-3%
Operating Margin--0.0410.0410%0.040+2%0.041+1%0.040+4%
Operating Ratio--1.8721.8720%1.8740%1.505+24%1.233+52%
Pb Ratio0.8380%0.8410.8410%0.791+6%0.915-8%1.368-39%
Pe Ratio6.6940%6.7156.7150%6.308+6%9.719-31%14.874-55%
Price Per Share19.7800%19.84019.8400%16.960+17%23.402-15%26.356-25%
Price To Free Cash Flow Ratio3.0770%3.0873.0870%5.258-41%76.038-96%4.879-37%
Price To Total Gains Ratio6.6970%6.7176.7170%-1.889+128%4.677+44%9.840-32%
Quick Ratio--0.8840.8840%0.935-5%0.930-5%0.905-2%
Return On Assets--0.0230.0230%0.023+1%0.024-1%0.025-6%
Return On Equity--0.1250.1250%0.1250%0.129-3%0.126-1%
Total Gains Per Share--2.9542.9540%-8.979+404%1.393+112%1.864+58%
Usd Book Value--9400781915.5209400781915.5200%8546925910.913+10%10085083667.694-7%7823458528.661+20%
Usd Book Value Change Per Share--0.2740.2740%-1.242+554%0.091+202%0.171+60%
Usd Book Value Per Share--3.0123.0120%2.739+10%3.296-9%2.680+12%
Usd Dividend Per Share--0.1040.1040%0.095+9%0.087+19%0.068+53%
Usd Eps--0.3770.3770%0.343+10%0.320+18%0.257+47%
Usd Free Cash Flow--2561378254.0482561378254.0480%1285517505.080+99%1532630278.307+67%1142617747.391+124%
Usd Free Cash Flow Per Share--0.8210.8210%0.412+99%0.498+65%0.388+111%
Usd Free Cash Flow To Equity Per Share--0.5690.5690%-0.238+142%0.310+83%0.288+98%
Usd Market Cap3389286051.103-133%7906394661.9867906394661.9860%6758691799.552+17%9092414125.681-13%9591647146.983-18%
Usd Price Per Share2.5260%2.5342.5340%2.166+17%2.988-15%3.366-25%
Usd Profit--1177457324.1951177457324.1950%1071527590.377+10%982219735.497+20%750971777.050+57%
Usd Revenue--76255745369.00376255745369.0030%71961109490.324+6%63500035071.881+20%47335037592.936+61%
Usd Total Gains Per Share--0.3770.3770%-1.147+404%0.178+112%0.238+58%
 EOD+4 -4MRQTTM+0 -0YOY+30 -55Y+23 -1310Y+25 -11

3.2. Fundamental Score

Let's check the fundamental score of Sinopharm Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.694
Price to Book Ratio (EOD)Between0-10.838
Net Profit Margin (MRQ)Greater than00.015
Operating Margin (MRQ)Greater than00.041
Quick Ratio (MRQ)Greater than10.884
Current Ratio (MRQ)Greater than11.359
Debt to Asset Ratio (MRQ)Less than10.813
Debt to Equity Ratio (MRQ)Less than14.359
Return on Equity (MRQ)Greater than0.150.125
Return on Assets (MRQ)Greater than0.050.023
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Sinopharm Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.389
Ma 20Greater thanMa 5020.106
Ma 50Greater thanMa 10020.946
Ma 100Greater thanMa 20020.257
OpenGreater thanClose19.840
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets364,775,134
Total Liabilities296,706,575
Total Stockholder Equity68,068,559
 As reported
Total Liabilities 296,706,575
Total Stockholder Equity+ 68,068,559
Total Assets = 364,775,134

Assets

Total Assets364,775,134
Total Current Assets319,406,382
Long-term Assets45,368,752
Total Current Assets
Cash And Cash Equivalents 55,221,624
Short-term Investments 498
Net Receivables 152,584,842
Inventory 60,925,831
Other Current Assets 24,326,811
Total Current Assets  (as reported)319,406,382
Total Current Assets  (calculated)293,059,606
+/- 26,346,776
Long-term Assets
Property Plant Equipment 17,792,353
Goodwill 7,155,580
Intangible Assets 3,015,339
Other Assets 5,784,645
Long-term Assets  (as reported)45,368,752
Long-term Assets  (calculated)33,747,917
+/- 11,620,835

Liabilities & Shareholders' Equity

Total Current Liabilities234,962,957
Long-term Liabilities19,742,987
Total Stockholder Equity68,068,559
Total Current Liabilities
Short Long Term Debt 52,997,246
Accounts payable 137,085,061
Other Current Liabilities 33,673,233
Total Current Liabilities  (as reported)234,962,957
Total Current Liabilities  (calculated)223,755,540
+/- 11,207,417
Long-term Liabilities
Long term Debt Total 14,956,993
Other Liabilities 4,785,994
Deferred Long Term Liability 74,436
Long-term Liabilities  (as reported)19,742,987
Long-term Liabilities  (calculated)19,817,423
+/- 74,436
Total Stockholder Equity
Common Stock3,120,656
Retained Earnings 44,700,833
Capital Surplus 24,641,485
Other Stockholders Equity -4,390,577
Total Stockholder Equity (as reported)68,068,559
Total Stockholder Equity (calculated)68,072,397
+/- 3,838
Other
Capital Stock3,120,656
Cash and Short Term Investments 55,222,122
Common Stock Shares Outstanding 3,120,656
Liabilities and Stockholders Equity 364,775,134
Net Debt 9,526,055
Net Invested Capital 132,816,238
Net Tangible Assets 57,972,076
Net Working Capital 84,443,425
Property Plant and Equipment Gross 32,080,584



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
11,590,265
14,287,261
16,114,897
28,275,250
42,014,480
67,627,852
79,847,109
105,453,110
128,655,739
138,267,028
157,711,590
169,539,028
235,771,077
269,888,371
311,236,706
335,412,321
364,775,134
364,775,134335,412,321311,236,706269,888,371235,771,077169,539,028157,711,590138,267,028128,655,739105,453,11079,847,10967,627,85242,014,48028,275,25016,114,89714,287,26111,590,265
   > Total Current Assets 
9,397,590
11,955,288
13,681,470
25,287,235
34,863,300
56,233,061
66,016,320
89,713,376
110,272,464
116,752,068
132,759,719
144,843,393
204,654,573
229,999,688
267,609,973
290,922,141
319,406,382
319,406,382290,922,141267,609,973229,999,688204,654,573144,843,393132,759,719116,752,068110,272,46489,713,37666,016,32056,233,06134,863,30025,287,23513,681,47011,955,2889,397,590
       Cash And Cash Equivalents 
1,838,797
1,955,596
1,712,119
6,937,243
7,474,698
13,091,012
9,721,992
14,001,962
15,232,356
19,919,154
25,572,759
29,011,436
40,298,985
39,191,967
50,178,265
43,529,428
55,221,624
55,221,62443,529,42850,178,26539,191,96740,298,98529,011,43625,572,75919,919,15415,232,35614,001,9629,721,99213,091,0127,474,6986,937,2431,712,1191,955,5961,838,797
       Short-term Investments 
15
15
15
15
990
1,163
1,559
1,122
728
2,069
5,468
175,614
41,199
156
39,141
11,749
498
49811,74939,14115641,199175,6145,4682,0697281,1221,5591,16399015151515
       Net Receivables 
5,067,495
6,376,969
8,042,801
13,564,796
18,043,570
27,379,436
37,956,645
52,669,141
67,070,535
58,345,555
72,780,527
84,914,018
110,363,727
126,563,237
146,049,207
161,397,269
152,584,842
152,584,842161,397,269146,049,207126,563,237110,363,72784,914,01872,780,52758,345,55567,070,53552,669,14137,956,64527,379,43618,043,57013,564,7968,042,8016,376,9695,067,495
       Inventory 
2,043,361
2,634,374
3,154,820
4,272,807
7,530,376
12,214,060
13,618,051
16,702,338
20,308,570
22,348,576
25,759,525
26,768,692
35,388,863
42,594,396
47,085,450
51,499,625
60,925,831
60,925,83151,499,62547,085,45042,594,39635,388,86326,768,69225,759,52522,348,57620,308,57016,702,33813,618,05112,214,0607,530,3764,272,8073,154,8202,634,3742,043,361
       Other Current Assets 
291,916
301,530
441,527
417,174
1,061,842
1,854,335
2,592,413
2,423,976
2,318,367
5,830,613
7,422,998
13,523,930
16,878,103
19,447,934
24,257,910
16,796,413
24,326,811
24,326,81116,796,41324,257,91019,447,93416,878,10313,523,9307,422,9985,830,6132,318,3672,423,9762,592,4131,854,3351,061,842417,174441,527301,530291,916
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
24,951,871
24,695,635
31,116,504
39,888,683
43,626,733
44,490,180
45,368,752
45,368,75244,490,18043,626,73339,888,68331,116,50424,695,63524,951,8710000000000
       Property Plant Equipment 
1,087,957
1,192,945
1,257,019
1,447,946
3,330,750
4,430,655
5,382,461
6,310,547
7,102,276
7,642,496
6,752,464
9,008,497
11,025,136
16,271,966
17,065,920
17,597,506
17,792,353
17,792,35317,597,50617,065,92016,271,96611,025,1369,008,4976,752,4647,642,4967,102,2766,310,5475,382,4614,430,6553,330,7501,447,9461,257,0191,192,9451,087,957
       Goodwill 
25,860
25,860
30,593
123,827
687,559
2,878,618
3,396,955
3,466,040
3,723,888
3,997,101
3,834,871
4,127,286
4,899,384
5,664,072
7,287,394
7,199,009
7,155,580
7,155,5807,199,0097,287,3945,664,0724,899,3844,127,2863,834,8713,997,1013,723,8883,466,0403,396,9552,878,618687,559123,82730,59325,86025,860
       Long Term Investments 
0
0
0
0
0
0
0
1,005,440
1,278,575
1,455,691
3,792,910
6,283,149
7,065,114
0
0
0
0
00007,065,1146,283,1493,792,9101,455,6911,278,5751,005,4400000000
       Intangible Assets 
613,669
601,784
606,967
895,451
2,257,087
5,574,947
2,152,539
2,137,249
2,624,122
2,722,868
2,447,901
2,546,893
2,577,350
3,324,778
10,729,302
10,391,727
3,015,339
3,015,33910,391,72710,729,3023,324,7782,577,3502,546,8932,447,9012,722,8682,624,1222,137,2492,152,5395,574,9472,257,087895,451606,967601,784613,669
       Long-term Assets Other 
12,579
4,783
5,185
19,387
637,726
222,278
113,266
120,352
315,547
180,755
165,522
184,900
322,376
674,676
3,259,496
3,119,147
988,048
988,0483,119,1473,259,496674,676322,376184,900165,522180,755315,547120,352113,266222,278637,72619,3875,1854,78312,579
> Total Liabilities 
9,000,004
11,668,913
12,704,315
15,770,795
27,295,400
47,239,766
57,103,908
76,841,760
92,366,110
97,611,323
113,179,154
118,269,374
167,495,310
192,949,004
221,289,385
273,526,306
296,706,575
296,706,575273,526,306221,289,385192,949,004167,495,310118,269,374113,179,15497,611,32392,366,11076,841,76057,103,90847,239,76627,295,40015,770,79512,704,31511,668,9139,000,004
   > Total Current Liabilities 
8,269,708
10,946,892
11,877,776
14,754,855
25,754,076
40,291,560
50,105,470
70,841,179
86,019,825
94,682,070
99,737,359
110,876,304
160,074,381
178,424,634
203,977,099
219,306,549
234,962,957
234,962,957219,306,549203,977,099178,424,634160,074,381110,876,30499,737,35994,682,07086,019,82570,841,17950,105,47040,291,56025,754,07614,754,85511,877,77610,946,8928,269,708
       Short-term Debt 
1,704,351
2,161,596
1,504,170
1,284,313
3,344,182
8,666,785
10,888,203
21,007,276
25,232,854
28,203,994
22,362,578
30,162,908
50,085,218
42,476,715
54,958,954
0
0
0054,958,95442,476,71550,085,21830,162,90822,362,57828,203,99425,232,85421,007,27610,888,2038,666,7853,344,1821,284,3131,504,1702,161,5961,704,351
       Short Long Term Debt 
0
0
0
0
0
0
0
25,141,343
25,232,854
28,355,283
22,362,578
30,162,908
50,085,218
42,476,715
54,958,954
55,151,650
52,997,246
52,997,24655,151,65054,958,95442,476,71550,085,21830,162,90822,362,57828,355,28325,232,85425,141,3430000000
       Accounts payable 
5,629,948
7,209,584
9,053,071
12,135,002
19,831,205
27,053,995
34,685,397
44,188,111
54,723,653
59,563,296
66,821,896
72,492,039
83,682,927
100,333,768
112,632,393
128,431,227
137,085,061
137,085,061128,431,227112,632,393100,333,76883,682,92772,492,03966,821,89659,563,29654,723,65344,188,11134,685,39727,053,99519,831,20512,135,0029,053,0717,209,5845,629,948
       Other Current Liabilities 
935,409
1,575,712
1,306,345
1,071,935
2,301,425
4,570,780
4,531,870
5,645,792
6,063,318
5,195,890
7,479,052
15,767,666
20,996,729
28,066,461
9,010,526
25,821,340
33,673,233
33,673,23325,821,3409,010,52628,066,46120,996,72915,767,6667,479,0525,195,8906,063,3185,645,7924,531,8704,570,7802,301,4251,071,9351,306,3451,575,712935,409
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
13,441,795
7,393,070
7,420,929
14,524,370
17,312,286
16,451,837
19,742,987
19,742,98716,451,83717,312,28614,524,3707,420,9297,393,07013,441,7950000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
758,212
11,204,754
5,594,215
5,019,101
11,470,335
12,161,737
11,668,550
14,956,993
14,956,99311,668,55012,161,73711,470,3355,019,1015,594,21511,204,754758,212000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
83,614
67,934
4,289,689
4,649,150
4,797,916
4,842,507
4,842,5074,797,9164,649,1504,289,68967,93483,61400000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
209,166
139,535
247,016
579,034
3,590,931
3,316,048
185,391
185,3913,316,0483,590,931579,034247,016139,535209,1660000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
41,310
76,861
57,528
32,109
46,558
50,047
66,345
81,261
76,608
74,436
74,43676,60881,26166,34550,04746,55832,10957,52876,86141,3100000000
> Total Stockholder Equity
1,759,628
1,683,759
2,264,230
10,910,856
11,711,138
15,673,849
17,078,291
21,815,546
27,381,867
30,110,310
31,810,928
38,301,481
42,821,826
47,422,146
56,358,845
61,886,015
68,068,559
68,068,55961,886,01556,358,84547,422,14642,821,82638,301,48131,810,92830,110,31027,381,86721,815,54617,078,29115,673,84911,711,13810,910,8562,264,2301,683,7591,759,628
   Common Stock
1,637,037
1,637,037
1,637,037
2,264,568
2,264,568
2,402,625
2,402,625
2,568,293
2,767,095
2,767,095
2,767,095
2,767,095
2,971,656
2,971,656
3,120,656
3,120,656
3,120,656
3,120,6563,120,6563,120,6562,971,6562,971,6562,767,0952,767,0952,767,0952,767,0952,568,2932,402,6252,402,6252,264,5682,264,5681,637,0371,637,0371,637,037
   Retained Earnings 
117,448
34,409
375,168
510,871
1,511,100
2,663,854
4,053,399
5,312,091
7,800,114
10,034,577
13,437,539
21,096,912
23,089,675
27,588,043
53,238,189
38,515,779
44,700,833
44,700,83338,515,77953,238,18927,588,04323,089,67521,096,91213,437,53910,034,5777,800,1145,312,0914,053,3992,663,8541,511,100510,871375,16834,409117,448
   Capital Surplus 
0
0
0
0
0
0
0
0
0
18,077,173
18,077,173
18,077,173
21,223,102
21,223,102
24,641,485
24,641,485
24,641,485
24,641,48524,641,48524,641,48521,223,10221,223,10218,077,17318,077,17318,077,173000000000
   Treasury Stock00000-193,00300000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
-294,410
-1,262,515
-1,374,531
-3,186,748
-3,446,696
-4,327,289
-4,300,443
53,242,027
-4,388,067
-4,390,577
-4,390,577-4,388,06753,242,027-4,300,443-4,327,289-3,446,696-3,186,748-1,374,531-1,262,515-294,4100000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue591,685,676
Cost of Revenue--
Gross Profit-591,685,676
 
Operating Income (+$)
Gross Profit-
Operating Expense-568,483,753
Operating Income23,201,923-568,483,753
 
Operating Expense (+$)
Research Development-
Selling General Administrative25,938,486
Selling And Marketing Expenses-
Operating Expense568,483,75325,938,486
 
Net Interest Income (+$)
Interest Income-
Interest Expense-3,294,981
Other Finance Cost-330,334
Net Interest Income-2,964,647
 
Pretax Income (+$)
Operating Income23,201,923
Net Interest Income-2,964,647
Other Non-Operating Income Expenses-
Income Before Tax (EBT)19,000,57923,201,923
EBIT - interestExpense = -3,294,981
8,765,042
12,060,024
Interest Expense3,294,981
Earnings Before Interest and Taxes (EBIT)-22,295,560
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax19,000,579
Tax Provision-4,400,314
Net Income From Continuing Ops14,600,26514,600,265
Net Income8,765,042
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,964,647
 

Technical Analysis of Sinopharm Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sinopharm Group Co Ltd. The general trend of Sinopharm Group Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sinopharm Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sinopharm Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 21.10 < 22.80 < 22.95.

The bearish price targets are: 17.44 > 17.18 > 17.14.

Tweet this
Sinopharm Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sinopharm Group Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sinopharm Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sinopharm Group Co Ltd. The current macd is -0.35980526.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sinopharm Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sinopharm Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sinopharm Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sinopharm Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSinopharm Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sinopharm Group Co Ltd. The current adx is 22.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sinopharm Group Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sinopharm Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sinopharm Group Co Ltd. The current sar is 20.35.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sinopharm Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sinopharm Group Co Ltd. The current rsi is 43.39. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Sinopharm Group Co Ltd Daily Relative Strength Index (RSI) ChartSinopharm Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sinopharm Group Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinopharm Group Co Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Sinopharm Group Co Ltd Daily Stochastic Oscillator ChartSinopharm Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sinopharm Group Co Ltd. The current cci is -43.57338757.

Sinopharm Group Co Ltd Daily Commodity Channel Index (CCI) ChartSinopharm Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sinopharm Group Co Ltd. The current cmo is -12.63290934.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sinopharm Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartSinopharm Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sinopharm Group Co Ltd. The current willr is -69.47368421.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sinopharm Group Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sinopharm Group Co Ltd Daily Williams %R ChartSinopharm Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sinopharm Group Co Ltd.

Sinopharm Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sinopharm Group Co Ltd. The current atr is 0.68426334.

Sinopharm Group Co Ltd Daily Average True Range (ATR) ChartSinopharm Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sinopharm Group Co Ltd. The current obv is 287,521,979.

Sinopharm Group Co Ltd Daily On-Balance Volume (OBV) ChartSinopharm Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sinopharm Group Co Ltd. The current mfi is 54.44.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sinopharm Group Co Ltd Daily Money Flow Index (MFI) ChartSinopharm Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sinopharm Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Sinopharm Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sinopharm Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.389
Ma 20Greater thanMa 5020.106
Ma 50Greater thanMa 10020.946
Ma 100Greater thanMa 20020.257
OpenGreater thanClose19.840
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sinopharm Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sinopharm Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sinopharm Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sinopharm Group Co Ltd

I send you an email if I find something interesting about Sinopharm Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sinopharm Group Co Ltd.

Receive notifications about Sinopharm Group Co Ltd in your mailbox!